Display Settings:

Format

Send to:

Choose Destination
    Vaccine. 2009 Oct 30;27(46):6454-9. Epub 2009 Jun 24.

    Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system.

    Source

    Nature Technology Corporation, 4701 Innovation Drive, Lincoln, NE 68521, USA.

    Abstract

    To ensure safety, regulatory agencies recommend elimination of antibiotic resistance markers from therapeutic and vaccine plasmid DNA vectors. Here, we describe the development and application of a novel antibiotic-free selection system. Vectors incorporate and express a 150 bp RNA-OUT antisense RNA. RNA-OUT represses expression of a chromosomally integrated constitutively expressed counter-selectable marker (sacB), allowing plasmid selection on sucrose. Sucrose selectable DNA vaccine vectors combine antibiotic-free selection with highly productive fermentation manufacturing (>1g/L plasmid DNA yields), while improving in vivo expression of encoded proteins and increasing immune responses to target antigens. These vectors are safer, more potent, alternatives for DNA therapy or vaccination.

    PMID:
    19559109
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2767433
    Free PMC Article

    Images from this publication.See all images (5) Free text

    Fig. 2
    Fig. 4
    Fig. 1
    Fig. 3
    Fig. 5

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk